%PDF-1.4
%
22 0 obj
<>
endobj
21 0 obj
<>stream
Acrobat Distiller 7.0 (Windows)
16th June 2017
0-00-00T20:17:00Z
2017-06-19T12:27:54-07:00
Arbortext Advanced Print Publisher 9.1.510/W Unicode
2017-06-19T12:27:54-07:00
application/pdf
Aryl hydrocarbon receptor activity may serve as a surrogate marker for MS disease activity
uuid:905606e1-c646-4710-949f-56a527cd8b94
uuid:ca135de0-1dd1-11b2-0a00-d20028b7d0ff
16th June 2017
endstream
endobj
18 0 obj
<>
endobj
2 0 obj
<>
endobj
20 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI]/Properties<>/XObject<>>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
69 0 obj
<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
72 0 obj
[79 0 R 80 0 R 81 0 R 82 0 R]
endobj
73 0 obj
<>stream
q
367.5943909 0 0 102.3984375 112.7028046 607.6015625 cm
/Im0 Do
Q
BT
/T1_0 1 Tf
12 0 0 12 203.00812 519.99988 Tm
(DOI 10.1212/NXI.0000000000000366)Tj
13.91601 1 Td
(2017;4; )Tj
/T1_1 1 Tf
-15.30604 0 Td
(Neurol Neuroimmunol Neuroinflamm\240)Tj
/T1_0 1 Tf
0.79202 1.00001 Td
(Joseph J. Sabatino, Jr and Scott S. Zamvil)Tj
/T1_2 1 Tf
6.68101 1 Td
(activity)Tj
-16.205 1 Td
(Aryl hydrocarbon receptor activity may serve as a surrogate marker for M\
S disease)Tj
ET
BT
/T1_2 1 Tf
12 0 0 12 176.99808 493 Tm
(This information is current as of June 16, 2017)Tj
ET
72 348 449 137 re
0 0 m
S
BT
/T1_2 1 Tf
10 0 0 10 82 455.99997 Tm
(Services)Tj
0 1 TD
(Updated Information &)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 431.0098 455.99997 Tm
( )Tj
0 0 1 rg
-20.00098 0 Td
(http://nn.neurology.org/content/4/4/e366.full.html)Tj
0 g
T*
(including high resolution figures, can be found at:)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 82 433 Tm
(References)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 475.99957 422.99997 Tm
( )Tj
0 0 1 rg
-24.49996 0 Td
(http://nn.neurology.org/content/4/4/e366.full.html##ref-list-1)Tj
0 g
T*
(This article cites 10 articles, 4 of which you can access for free at: )Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 82 394.99997 Tm
(\240 )Tj
/T1_2 1 Tf
T*
(Permissions & Licensing)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 449.0701 384.99994 Tm
( )Tj
0 0 1 rg
-21.80701 0 Td
(http://nn.neurology.org/misc/about.xhtml#permissions)Tj
0 g
T*
(its entirety can be found online at:)Tj
0 1.00001 TD
(Information about reproducing this article in parts \(figures,tables\) o\
r in)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 82 356.99997 Tm
(\240 )Tj
/T1_2 1 Tf
0 1 TD
(Reprints)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 439.05988 356.99997 Tm
( )Tj
0 0 1 rg
-20.80599 0 Td
(http://nn.neurology.org/misc/addir.xhtml#reprintsus)Tj
0 g
T*
(Information about ordering reprints can be found online:)Tj
ET
72 173 449 56 re
0 0 m
S
BT
/T1_0 1 Tf
10 0 0 10 77 180.99991 Tm
(Academy of Neurology.. All rights reserved. Online ISSN: 2332-7812.)Tj
T*
(Copyright \251 2017 The Author\(s\). Published by Wolters Kluwer Health,\
Inc. on behalf of the American)Tj
0 1.00001 TD
(Published since April 2014, it is an open-access, online-only, continuou\
s publication journal. Copyright )Tj
15.30605 1 Td
(is an official journal of the American Academy of Neurology.)Tj
/T1_1 1 Tf
-15.30605 0 Td
(Neurol Neuroimmunol Neuroinflamm\240)Tj
ET
q
246.75 0 0 77.25 173.125 77.75 cm
-1.00001 TL /Im1 Do
Q
endstream
endobj
77 0 obj
<>/Filter/FlateDecode/Height 256/Length 83633/Name/X/Subtype/Image/Type/XObject/Width 919>>stream
H{PT\.`u13"PLb}<4+˂ڸ2QpР`TRHGvӉ@")Xޞ{{,wQg.=7sAP
yTcL'/!O]ݙa ;FWXUUW[]yrT a2F4{2RVHu0*+*nw+*)Մ
0J2P>Y+/BKdTЏf*{~mf_j]}cC5N /LbUiN8|5L7=L)C?+m)xPyQ2MH+ ؾGsy7Z&CZE*8Vdd]>>>4y-4JD6n#=[opew `0fi^!OP CV`,^nA;w%QCJ/*.5k$f@7ֱ`^xK?K ^frnZZFV)!^2y_Ydd|ưsPMuT#Gϛ;gF'e*uph Bb#kKkCCCͥ'i
8az55S5K{=
˿@paaι>o
Wzp-Eط#CB.
/ v+ן~@!">(9GS:A}@Wf:k2Ml.X*)kJ ;%*\۵;z,;XOqϳckV>jO̬_TqSFھɚL)coL?e=$9dKd( ǁRXa}*!2K>[h
cnu]Z9ZNfN__[
u-vɮ&F KٛVb*|bD58j1fxzNbHv eI\LltVC8"TT?uAb
/} ^,H(WT&ӂTJZ59هsQ2|Ԋw"]:?p2"}<_-tvw6)